Drawing for SCIENSUS INSIGHTS+

USPTO serial 99321205

SCIENSUS INSIGHTS+

Reviewed by CopyMark Law Group

Status 661
Filing date
Status date
Registration date
—
Examiner
RODRIGUEZ FONTANE, KIARA
Law office
TMO LAW OFFICE 126

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with SCIENSUS INSIGHTS+?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Christine Lebron-Dykeman

Christine Lebron-Dykeman McKee, Voorhees & Sease, P.L.C.801 Grand Ave., Ste. 3200Des Moines, IA 50309-2721United States

Goods and services

ClassDescriptionStatusFirst use
009Downloadable computer software for monitoring patient health, analyzing medical and healthcare data, accessing medical data, managing medical records, and customizing treatment plans; downloadable health monitoring software; downloadable software in the nature of a health monitoring mobile application; downloadable educational software relating to healthcare, namely, software featuring instruction in the field of healthcare for patients and clinicians; downloadable software in the nature of an educational mobile application relating to healthcare for patients and clinicians; downloadable computer software for analyzing medical and healthcare data and accessing medical records for use in medical decision support systems; downloadable computer software using artificial intelligence for healthcare, namely, software for accessing and analyzing medical and healthcare data using machine learning algorithms; downloadable virtual reality software for medical teaching; downloadable software for analysis of medical and healthcare dataACTIVE—
035Data collection services in the nature of maintaining personal medical history records and files; compilation of statistical data relating to medical research for business purposes; provision of business statistical information relating to medical mattersACTIVE—
038Electronic data exchange services, namely, electronic exchange of medical records across a nationwide health information network; providing information in the field of telecommunications; electronic data transmission; data transfer by telecommunications services; communications services for the exchange of data in electronic form, namely, providing access to an electronic exchange of medical records across a nationwide health information network; electronic exchange of data stored in databases accessible via telecommunication networks; electronic data exchange, storage and transfer services for the healthcare, pharmaceutical and medical industryACTIVE—
042Design and development of computer hardware and software; Non-downloadable software as a service [SaaS] for providing aggregated pharmaceutical and healthcare market data; generating analytics, dashboards, and reports; monitoring medication distribution trends; accessing and visualizing healthcare service data; and supporting pharmaceutical commercial decision-making; Non-downloadable software as a service [SaaS] for providing aggregated pharmaceutical and healthcare market data; generating analytics, dashboards, and reports; monitoring medication distribution trends; accessing and visualizing healthcare service data; and supporting pharmaceutical commercial decision-making for use in the healthcare, pharmaceutical and medical industry; computer software design; application software design and development; software design and development for the healthcare, pharmaceutical and medical industry; Development of application software for delivery of multimedia content; technical support services relating to computer software and applications; providing temporary use of non-downloadable software applications for providing aggregated pharmaceutical and healthcare market data; generating analytics, dashboards, and reports; monitoring medication distribution trends; accessing and visualizing healthcare service data; and supporting pharmaceutical commercial decision-making accessible via a web site; medical research services; scientific research in the field of pharmacy; pharmacological research services; electronic storage of data; electronic storage of data for the healthcare, pharmaceutical and medical industry; electronic data storage services; design and development of data storage systems; information and advice in relation to the aforesaidACTIVE—
044Healthcare services in the field of viral and infectious diseases, for the treatment of cancer and for the treatment of Multiple Sclerosis (MS), anaemia, schizophrenia, pneumonia, fertility, blood disorder, cystic fibrosis, Gastroenteropancreatic (GEP) tumours, hepatitis B and C, lung disease; pharmaceutical services, namely, dispensing of pharmaceuticals, pharmaceutical advice, pharmaceutical compounding services; medical services; dentistry services; health assessment services; health care services in domestic homes; healthcare consultancy in the field of viral and infectious diseases, for the treatment of cancer and for the treatment of rare diseases and orphan diseases; medical analysis for the diagnosis and treatment of persons, namely, x-ray examinations and taking blood samples; pharmacy advice, namely, providing advice relating to preparation of prescriptions in pharmacies; provision of nursing care; pharmaceutical advisory services, namely, pharmaceutical advice; health care services, namely, collection of information in the healthcare sector relating to the use of pharmaceutical products and patient-medication behaviour for treatment and diagnostic purposes; medical clinical services; healthcare services, namely, development and design of home health care plans and packages in the nature of developing and providing personal home health care assessments and personalized home health care routines, maintenance schedules, and counseling; pharmacists' services to make up prescriptions; medical analysis services for the treatment of patients; providing healthcare information by telephone; home healthcare services; home nursing aid services; provision of health care services in domestic homes; outpatient and inpatient care services; provision of medical treatment of viral and infectious diseases, for the treatment of cancer, and for the treatment of rare diseases and orphan diseases, Multiple Sclerosis (MS), anaemia, schizophrenia, pneumonia, fertility, blood disorder, cystic fibrosis, Gastroenteropancreatic (GEP) tumours, hepatitis B and C, lung disease; medical and healthcare information servicesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Mar 17, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 17, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 17, 2026TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 18, 2025GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 18, 2025GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 18, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 18, 2025DOCKASSIGNED TO EXAMINER—
Dec 13, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 5, 2025MAFRAPPLICATION FILING RECEIPT MAILED—
Aug 5, 2025NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance